サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1786875

バイオマーカー市場、規模、シェア、動向、産業分析：タイプ別、研究分野別、技術別、疾患適応症別、用途別、地域別、2025年～2034年の市場予測

Biomarkers Market Size, Share, Trends, & Industry Analysis By Type, (Safety Biomarkers, Efficacy Biomarkers, and Validation Biomarkers), By Research Area, By Technology, By Disease Indication, By Application, and By Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 129 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
バイオマーカー市場、規模、シェア、動向、産業分析：タイプ別、研究分野別、技術別、疾患適応症別、用途別、地域別、2025年～2034年の市場予測
出版日: 2025年07月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、バイオマーカーの市場規模は2034年までに1,467億8,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

世界のバイオマーカー市場は、臨床診断、製薬研究、健康モニタリングの各プロセスで利用が拡大しており、拡大を続けています。タンパク質、遺伝子、代謝物アッセイなどのバイオマーカーは、健康状態や疾患の有無を測定する生物学的指標として機能します。血液、組織、尿などのサンプルは通常、医療や研究目的でこれらの指標を分析するために実験室で使用されます。

バイオマーカーの採用は、病院、診断ラボ、研究センターにおける一般的な健康評価や高度な臨床評価において増加しています。臨床ワークフローを改善し、より多くの情報に基づいた医療上の意思決定をサポートするバイオマーカーの役割は、ラボの手法がより洗練され、利用しやすくなるにつれて拡大し続けています。

バイオマーカー市場レポートハイライト

研究分野別では、主に遺伝的変異の検出、疾患感受性の評価、治療領域全体にわたる精密医療アプローチの実現における広範な応用により、ゲノミクス分野が2024年の市場で主導的地位を占めました。

技術面では、次世代シーケンシング技術が予測期間中に最も急速な市場拡大を遂げると予測されています。この成長の加速は、包括的なバイオマーカー探索を促進するハイスループット・ゲノム解析のためのNGSの比類ない能力を反映しています。

北米は2024年にバイオマーカー市場で最大のシェアを獲得したが、これはこの地域に革新的なバイオ製薬企業、先進的な診断研究所が集中していること、精密医療の研究開発イニシアチブに多額の投資が行われていることに支えられています。

アジア太平洋地域のバイオマーカー市場は、ヘルスケアインフラの急速な改善、先端診断技術の採用拡大、新興経済圏における生物医学研究能力の拡大が牽引し、予測期間中に最も高い成長率を示すと予測されます。

世界の主な市場参入企業には、Abbott Laboratories、Agilent Technologies, Inc.、BioMerieux SA、Bio-Rad Laboratories, Inc.、Charles River Laboratories International, Inc.、Eurofins Scientific SE、F. Hoffmann-La Roche Ltd.、Guardant Health, Inc.、Illumina, Inc.、Merck KGaA、QIAGEN N.V.、Revvity, Inc.などがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のバイオマーカー市場の洞察

  • 市場スナップショット
  • バイオマーカー市場力学
    • 促進要因と機会
      • 慢性疾患の有病率の上昇
      • ゲノミクスとプロテオミクスの進歩
    • 抑制要因と課題
      • バイオマーカーの検証と開発高コスト
      • 規制の不確実性と長期にわたる承認プロセス
  • PESTEL分析
  • バイオマーカー市場の動向
  • バリューチェーン分析

第5章 世界のバイオマーカー市場：タイプ別

  • 主な調査結果
  • イントロダクション
  • 安全性バイオマーカー
  • 有効性バイオマーカー
  • 検証バイオマーカー

第6章 世界のバイオマーカー市場：研究分野別

  • 主な調査結果
  • イントロダクション
  • ゲノミクス
  • プロテオミクス
  • メタボロミクス
  • その他の研究分野

第7章 世界のバイオマーカー市場：技術別

  • 主な調査結果
  • イントロダクション
  • 免疫測定
  • 次世代シーケンシング（NGS）
  • ポリメラーゼ連鎖反応（PCR）
  • 質量分析
  • クロマトグラフィー
  • その他の技術

第8章 世界のバイオマーカー市場：疾患適応症別

  • 主な調査結果
  • イントロダクション
  • がん
  • 感染症
  • 免疫疾患
  • 政府および公共部門
  • 神経疾患
  • 心血管疾患
  • その他の疾患適応症

第9章 世界のバイオマーカー市場：用途別

  • 主な調査結果
  • イントロダクション
  • 臨床診断
  • 医薬品の発見と開発
  • パーソナライズ医療
  • 臨床調査
  • その他の用途

第10章 世界のバイオマーカー市場：地域別

  • 主な調査結果
  • イントロダクション
    • バイオマーカー市場評価：地域別、2020～2034年
  • 北米
    • 北米：タイプ別、2020～2034年
    • 北米：研究分野別、2020～2034年
    • 北米：技術別、2020～2034年
    • 北米：疾患適応症別、2020～2034年
    • 北米：用途別、2020～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：タイプ別、2020～2034年
    • 欧州：研究分野別、2020～2034年
    • 欧州：技術別、2020～2034年
    • 欧州：疾患適応症別、2020～2034年
    • 欧州：用途別、2020～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋地域：タイプ別、2020～2034年
    • アジア太平洋地域：研究分野別、2020～2034年
    • アジア太平洋地域：技術別、2020～2034年
    • アジア太平洋地域：疾患適応症別、2020年～2034年
    • アジア太平洋地域：用途別、2020～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：タイプ別、2020～2034年
    • 中東・アフリカ：研究分野別、2020～2034年
    • 中東・アフリカ：技術別、2020～2034年
    • 中東・アフリカ：疾患適応症別、2020年～2034年
    • 中東・アフリカ：用途別、2020～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ：タイプ別、2020～2034年
    • ラテンアメリカ：研究分野別、2020～2034年
    • ラテンアメリカ：技術別、2020～2034年
    • ラテンアメリカ：疾患適応症別、2020年～2034年
    • ラテンアメリカ：用途別、2020～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第11章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第12章 企業プロファイル

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • BioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Merck KGaA
  • QIAGEN N.V.
  • Revvity, Inc.
図表

List of Tables:

  • Table 1 Global Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 3 Global Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 4 Global Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 5 Global Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 7 North America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 8 North America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 9 North America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 10 North America: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 11 U.S.: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 12 U.S.: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 13 U.S.: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 14 U.S.: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 15 U.S.: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 16 Canada: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 17 Canada: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 18 Canada: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 19 Canada: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 20 Canada: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 21 Europe: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 22 Europe: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 23 Europe: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 24 Europe: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 25 Europe: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 26 UK: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 27 UK: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 28 UK: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 29 UK: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 30 UK: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 31 France: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 32 France: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 33 France: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 34 France: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 35 France: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Germany: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 37 Germany: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 38 Germany: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 39 Germany: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 40 Germany: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 41 Italy: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 42 Italy: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 43 Italy: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 44 Italy: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 45 Italy: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 46 Spain: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 47 Spain: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 48 Spain: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 49 Spain: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 50 Spain: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Netherlands: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 52 Netherlands: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 53 Netherlands: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 54 Netherlands: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 55 Netherlands: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 56 Russia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 57 Russia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 58 Russia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 59 Russia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 60 Russia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 61 Rest of Europe: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Rest of Europe: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 63 Rest of Europe: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 64 Rest of Europe: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 65 Rest of Europe: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Asia Pacific: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 67 Asia Pacific: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 68 Asia Pacific: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 69 Asia Pacific: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 70 Asia Pacific: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 71 China: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 72 China: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 73 China: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 74 China: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 75 China: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 76 India: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 77 India: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 78 India: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 79 India: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 80 India: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 81 Malaysia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 82 Malaysia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 83 Malaysia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 84 Malaysia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 85 Malaysia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 86 Japan: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 87 Japan: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 88 Japan: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 89 Japan: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 90 Japan: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 91 Indonesia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Indonesia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 93 Indonesia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 94 Indonesia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 95 Indonesia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 96 South Korea: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 97 South Korea: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 98 South Korea: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 99 South Korea: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 100 South Korea: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 101 Australia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 102 Australia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 103 Australia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 104 Australia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 105 Australia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 106 Rest of Asia Pacific: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 107 Rest of Asia Pacific: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 108 Rest of Asia Pacific: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 109 Rest of Asia Pacific: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 110 Rest of Asia Pacific: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 111 Middle East & Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 112 Middle East & Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 113 Middle East & Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 114 Middle East & Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 115 Middle East & Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 116 Saudi Arabia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 117 Saudi Arabia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 118 Saudi Arabia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 119 Saudi Arabia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 120 Saudi Arabia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 121 UAE: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 122 UAE: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 123 UAE: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 124 UAE: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 125 UAE: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 126 Israel: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 127 Israel: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 128 Israel: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 129 Israel: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 130 Israel: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 131 South Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 132 South Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 133 South Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 134 South Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 135 South Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 136 Rest of Middle East & Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 137 Rest of Middle East & Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 138 Rest of Middle East & Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 139 Rest of Middle East & Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 140 Rest of Middle East & Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 141 Latin America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 142 Latin America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 143 Latin America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 144 Latin America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 145 Latin America: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 146 Mexico: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 147 Mexico: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 148 Mexico: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 149 Mexico: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 150 Mexico: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 151 Brazil: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 152 Brazil: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 153 Brazil: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 154 Brazil: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 155 Brazil: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 156 Argentina: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 157 Argentina: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 158 Argentina: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 159 Argentina: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 160 Argentina: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 161 Rest of Latin America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 162 Rest of Latin America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 163 Rest of Latin America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 164 Rest of Latin America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 165 Rest of Latin America: Biomarkers Market, by Application, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Biomarkers Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Biomarkers Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Research Area
  • Figure 9. Global Biomarkers Market, by Research Area, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Technology
  • Figure 11. Global Biomarkers Market, by Technology, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Disease Indication
  • Figure 13. Global Biomarkers Market, by Disease Indication, 2024 & 2034 (USD Billion)
  • Figure 14. Market by Application
  • Figure 15. Global Biomarkers Market, by Application, 2024 & 2034 (USD Billion)
目次
Product Code: PM5934

The biomarkers market size is expected to reach USD 146.78 Billion by 2034, according to a new study by Polaris Market Research. The report "Biomarkers Market Size, Share, Trends, & Industry Analysis By Type, (Safety Biomarkers, Efficacy Biomarkers, and Validation Biomarkers), By Research Area, By Technology, By Disease Indication, By Application, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global biomarkers market continues to expand due to its growing use across clinical diagnostics, pharmaceutical research, and health monitoring processes. Biomarkers such as proteins, genes, and metabolites assays serve as biological indicators to measure health status or disease presence. Samples such as blood, tissue, and urine are typically used in laboratory settings to analyze these indicators for medical or research purposes.

The adoption of biomarkers is increasing in general health assessments and advanced clinical evaluations across hospitals, diagnostic labs, and research centers. The role of biomarkers in improving clinical workflows and supporting more informed medical decisions continues to grow as laboratory methods become more refined and accessible.

Biomarkers Market Report Highlights

Based on research area, the genomics segment held the leading market position in 2024, primarily due to its extensive application in detecting genetic variations, assessing disease susceptibility, and enabling precision medicine approaches across therapeutic areas.

In terms of technology, the next-generation sequencing technology is anticipated to experience the most rapid market expansion during the forecast period. This accelerated growth reflects NGS's unparalleled capacity for high-throughput genomic analysis, which facilitates comprehensive biomarker discovery

North America captured the largest share of the biomarkers market in 2024, a position supported by the region's concentration of innovative biopharmaceutical firms, advanced diagnostic laboratories, and substantial investments in precision medicine research and development initiatives.

The Asia Pacific biomarkers market is forecast to demonstrate the highest growth rate during the projection period, driven by rapid improvements in healthcare infrastructure, increasing adoption of advanced diagnostic technologies, and expanding capabilities in biomedical research across emerging economies in the region.

A few global key market players include Abbott Laboratories, Agilent Technologies, Inc., BioMerieux SA, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Guardant Health, Inc., Illumina, Inc., Merck KGaA, QIAGEN N.V., Revvity, Inc.

Polaris Market Research has segmented the market report on the basis of type, research area, technology, disease indication, application, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Safety Biomarkers

Efficacy Biomarkers

Validation Biomarkers

By Research Area Outlook (Revenue, USD Billion, 2020-2034)

Genomics

Proteomics

Metabolomics

Other Research Areas

By Technology Outlook (Revenue, USD Billion, 2020-2034)

Immunoassays

Next-Generation Sequencing (NGS)

Polymerase Chain Reaction (PCR)

Mass Spectrometry

Chromatography

Other Technologies

By Disease Indication Outlook (Revenue, USD Billion, 2020-2034)

Cancer

Infectious Disease

Immunological Disorders

Neurological Disorders

Cardiovascular Disorders

Other Disease Indications

By Application Outlook (Revenue, USD Billion, 2020-2034)

Clinical Diagnostics

Drug Discovery & Development

Personalized Medicine

Clinical Research

Other Application

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Biomarkers Market Insights

  • 4.1. Biomarkers Market - Market Snapshot
  • 4.2. Biomarkers Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Chronic Diseases
      • 4.2.1.2. Advancements in Genomics and Proteomics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Biomarker Validation and Development
      • 4.2.2.2. Regulatory Uncertainty and Lengthy Approval Processes
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Biomarkers Market Trends
  • 4.6. Value Chain Analysis

5. Global Biomarkers Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Safety Biomarkers
    • 5.3.1. Global Biomarkers Market, by Safety Biomarkers, by Region, 2020-2034 (USD Billion)
  • 5.4. Efficacy Biomarkers
      • 5.4.1.1. Global Biomarkers Market, by Efficacy Biomarkers, by Region, 2020-2034 (USD Billion)
    • 5.4.2. Global Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • 5.5. Validation Biomarkers
    • 5.5.1. Global Biomarkers Market, by Validation Biomarkers, by Region, 2020-2034 (USD Billion)

6. Global Biomarkers Market, by Research Area

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • 6.3. Genomics
    • 6.3.1. Global Biomarkers Market, by Genomics, by Region, 2020-2034 (USD Billion)
  • 6.4. Proteomics
    • 6.4.1. Global Biomarkers Market, by Proteomics, by Region, 2020-2034 (USD Billion)
  • 6.5. Metabolomics
    • 6.5.1. Global Biomarkers Market, by Metabolomics, by Region, 2020-2034 (USD Billion)
  • 6.6. Other Research Areas
    • 6.6.1. Global Biomarkers Market, by Other Research Areas, by Region, 2020-2034 (USD Billion)

7. Global Biomarkers Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • 7.3. Immunoassays
    • 7.3.1. Global Biomarkers Market, by Immunoassays, by Region, 2020-2034 (USD Billion)
  • 7.4. Next-Generation Sequencing (NGS)
    • 7.4.1. Global Biomarkers Market, by Next-Generation Sequencing (NGS), by Region, 2020-2034 (USD Billion)
  • 7.5. Polymerase Chain Reaction (PCR)
    • 7.5.1. Global Biomarkers Market, by Polymerase Chain Reaction (PCR), by Region, 2020-2034 (USD Billion)
  • 7.6. Mass Spectrometry
    • 7.6.1. Global Biomarkers Market, by Mass Spectrometry, by Region, 2020-2034 (USD Billion)
  • 7.7. Chromatography
    • 7.7.1. Global Biomarkers Market, by Chromatography, by Region, 2020-2034 (USD Billion)
  • 7.8. Other Technologies
    • 7.8.1. Global Biomarkers Market, by Other Technologies, by Region, 2020-2034 (USD Billion)

8. Global Biomarkers Market, by Disease Indication

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • 8.3. Cancer
    • 8.3.1. Global Biomarkers Market, by Cancer, by Region, 2020-2034 (USD Billion)
  • 8.4. Infectious Disease
    • 8.4.1. Global Biomarkers Market, by Infectious Disease, by Region, 2020-2034 (USD Billion)
  • 8.5. Immunological Disorders
    • 8.5.1. Global Biomarkers Market, by Immunological Disorders, by Region, 2020-2034 (USD Billion)
  • 8.6. Government & Public Sector
    • 8.6.1. Global Biomarkers Market, by Government & Public Sector, by Region, 2020-2034 (USD Billion)
  • 8.7. Neurological Disorders
    • 8.7.1. Global Biomarkers Market, by Neurological Disorders, by Region, 2020-2034 (USD Billion)
  • 8.8. Cardiovascular Disorders
    • 8.8.1. Global Biomarkers Market, by Cardiovascular Disorders, by Region, 2020-2034 (USD Billion)
  • 8.9. Other Disease Indications
    • 8.9.1. Global Biomarkers Market, by Other Disease Indications, by Region, 2020-2034 (USD Billion)

9. Global Biomarkers Market, by Application

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 9.3. Clinical Diagnostics
    • 9.3.1. Global Biomarkers Market, by Clinical Diagnostics, by Region, 2020-2034 (USD Billion)
  • 9.4. Drug Discovery & Development
    • 9.4.1. Global Biomarkers Market, by Drug Discovery & Development, by Region, 2020-2034 (USD Billion)
  • 9.5. Personalized Medicine
    • 9.5.1. Global Biomarkers Market, by Personalized Medicine, by Region, 2020-2034 (USD Billion)
  • 9.6. Clinical Research
    • 9.6.1. Global Biomarkers Market, by Clinical Research, by Region, 2020-2034 (USD Billion)
  • 9.7. Other Application
    • 9.7.1. Global Biomarkers Market, by Other Application, by Region, 2020-2034 (USD Billion)

10. Global Biomarkers Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Biomarkers Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 10.3. Biomarkers Market - North America
    • 10.3.1. North America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.3.2. North America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.3.3. North America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.3.4. North America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.3.5. North America: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.3.6. Biomarkers Market - U.S.
      • 10.3.6.1. U.S.: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.3.6.2. U.S.: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.3.6.3. U.S.: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.3.6.4. U.S.: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.3.6.5. U.S.: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.3.7. Biomarkers Market - Canada
      • 10.3.7.1. Canada: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.3.7.2. Canada: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.3.7.3. Canada: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.3.7.4. Canada: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.3.7.5. Canada: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.4. Biomarkers Market - Europe
    • 10.4.1. Europe: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.4.2. Europe: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.4.3. Europe: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.4.4. Europe: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.5. Europe: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.4.6. Biomarkers Market - UK
      • 10.4.6.1. UK: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.4.6.2. UK: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.4.6.3. UK: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.6.4. UK: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.6.5. UK: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.4.7. Biomarkers Market - France
      • 10.4.7.1. France: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.4.7.2. France: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.4.7.3. France: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.7.4. France: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.7.5. France: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.4.8. Biomarkers Market - Germany
      • 10.4.8.1. Germany: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.4.8.2. Germany: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.4.8.3. Germany: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.8.4. Germany: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.8.5. Germany: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.4.9. Biomarkers Market - Italy
      • 10.4.9.1. Italy: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.4.9.2. Italy: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.4.9.3. Italy: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.9.4. Italy: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.9.5. Italy: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.4.10. Biomarkers Market - Spain
      • 10.4.10.1. Spain: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.4.10.2. Spain: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.4.10.3. Spain: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.10.4. Spain: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.10.5. Spain: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.4.11. Biomarkers Market - Netherlands
      • 10.4.11.1. Netherlands: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.4.11.2. Netherlands: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.4.11.3. Netherlands: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.11.4. Netherlands: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.11.5. Netherlands: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.4.12. Biomarkers Market - Russia
      • 10.4.12.1. Russia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.4.12.2. Russia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.4.12.3. Russia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.12.4. Russia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.12.5. Russia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.4.13. Biomarkers Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.4.13.2. Rest of Europe: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.4.13.3. Rest of Europe: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.13.4. Rest of Europe: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.13.5. Rest of Europe: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.5. Biomarkers Market - Asia Pacific
    • 10.5.1. Asia Pacific: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.5.2. Asia Pacific: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.5.3. Asia Pacific: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.5.4. Asia Pacific: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.5. Asia Pacific: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.5.6. Biomarkers Market - China
      • 10.5.6.1. China: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.5.6.2. China: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.5.6.3. China: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.6.4. China: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.6.5. China: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.5.7. Biomarkers Market - India
      • 10.5.7.1. India: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.5.7.2. India: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.5.7.3. India: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.7.4. India: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.7.5. India: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.5.8. Biomarkers Market - Malaysia
      • 10.5.8.1. Malaysia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.5.8.2. Malaysia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.5.8.3. Malaysia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.8.4. Malaysia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.8.5. Malaysia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.5.9. Biomarkers Market - Japan
      • 10.5.9.1. Japan: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.5.9.2. Japan: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.5.9.3. Japan: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.9.4. Japan: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.9.5. Japan: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.5.10. Biomarkers Market - Indonesia
      • 10.5.10.1. Indonesia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.5.10.2. Indonesia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.5.10.3. Indonesia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.10.4. Indonesia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.10.5. Indonesia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.5.11. Biomarkers Market - South Korea
      • 10.5.11.1. South Korea: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.5.11.2. South Korea: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.5.11.3. South Korea: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.11.4. South Korea: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.11.5. South Korea: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.5.12. Biomarkers Market - Australia
      • 10.5.12.1. Australia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.5.12.2. Australia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.5.12.3. Australia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.12.4. Australia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.12.5. Australia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.5.13. Biomarkers Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.5.13.2. Rest of Asia Pacific: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.5.13.3. Rest of Asia Pacific: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.13.4. Rest of Asia Pacific: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.13.5. Rest of Asia Pacific: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.6. Biomarkers Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.6.2. Middle East & Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.6.3. Middle East & Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.6.4. Middle East & Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.6.5. Middle East & Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.6.6. Biomarkers Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.6.6.2. Saudi Arabia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.6.7. Biomarkers Market - UAE
      • 10.6.7.1. UAE: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.6.7.2. UAE: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.6.7.3. UAE: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.6.7.4. UAE: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.6.7.5. UAE: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.6.8. Biomarkers Market - Israel
      • 10.6.8.1. Israel: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.6.8.2. Israel: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.6.8.3. Israel: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.6.8.4. Israel: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.6.8.5. Israel: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.6.9. Biomarkers Market - South Africa
      • 10.6.9.1. South Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.6.9.2. South Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.6.9.3. South Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.6.9.4. South Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.6.9.5. South Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.6.10. Biomarkers Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.6.10.2. Rest of Middle East & Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.6.10.3. Rest of Middle East & Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.6.10.4. Rest of Middle East & Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.6.10.5. Rest of Middle East & Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.7. Biomarkers Market - Latin America
    • 10.7.1. Latin America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.7.2. Latin America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.7.3. Latin America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.7.4. Latin America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.7.5. Latin America: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.7.6. Biomarkers Market - Mexico
      • 10.7.6.1. Mexico: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.7.6.2. Mexico: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.7.6.3. Mexico: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.7.6.4. Mexico: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.7.6.5. Mexico: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.7.7. Biomarkers Market - Brazil
      • 10.7.7.1. Brazil: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.7.7.2. Brazil: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.7.7.3. Brazil: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.7.7.4. Brazil: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.7.7.5. Brazil: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.7.8. Biomarkers Market - Argentina
      • 10.7.8.1. Argentina: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.7.8.2. Argentina: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.7.8.3. Argentina: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.7.8.4. Argentina: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.7.8.5. Argentina: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.7.9. Biomarkers Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.7.9.2. Rest of Latin America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.7.9.3. Rest of Latin America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.7.9.4. Rest of Latin America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.7.9.5. Rest of Latin America: Biomarkers Market, by Application, 2020-2034 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Abbott Laboratories
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Agilent Technologies, Inc.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. BioMerieux SA
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Bio-Rad Laboratories, Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Charles River Laboratories International, Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Eurofins Scientific SE
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. F. Hoffmann-La Roche Ltd
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Guardant Health, Inc.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Illumina, Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Merck KGaA
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. QIAGEN N.V.
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. Revvity, Inc.
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development